MEDIWOUND LTD (MDWD) Stock Analyst Ratings
NASDAQ:MDWD - Nasdaq - IL0011316309 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 84% to MDWD. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 29.58. This target is 51.69% above the current price.
MDWD was analyzed by 10 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about MDWD.
In the previous month the buy percentage consensus was at a similar level.
MDWD was analyzed by 10 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-01-10 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-11-27 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-10-11 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-08-15 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-07-16 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-30 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-03-22 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-01-16 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-11-22 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-09-21 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-08-17 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2023-08-17 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-05-31 | Oppenheimer | Reiterate | Outperform -> Outperform |
| 2023-05-31 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-03-17 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-01-04 | HC Wainwright & Co. | Maintains | Buy |
| 2022-12-30 | Cowen & Co. | Maintains | Outperform |
| 2022-12-22 | Maxim Group | Initiate | Buy |
| 2022-12-21 | Oppenheimer | Maintains | Outperform |
| 2022-11-16 | HC Wainwright & Co. | Maintains | Buy |
| 2022-05-18 | Wells Fargo | Maintains | Overweight |
| 2021-08-17 | Aegis Capital | Maintains | Buy |
| 2021-08-11 | HC Wainwright & Co. | Maintains | Buy |
| 2021-03-02 | Aegis Capital | Initiate | Buy |